Citadel Advisors’s iHuman IH Stock Holding History
Bought
Maintained
Sold
Other funds holding IH
Citadel Advisors's IH Position: Q1 2026 in Review
Citadel Advisors increased its iHuman (IH) stake by 21% in Q1 2026, buying an estimated $8K and bringing the position to 25,028 shares worth $42.7K. The position accounts for ﹤0.01% of the portfolio, ranked #12461.
Citadel Advisors first reported a position in IH in Q2 2021 and has held it in 12 quarters since. The position peaked at $516K in Q2 2021. 7 funds tracked by Wall St. Rank hold IH as of Q1 2026.
- Citadel Advisors held 25,028 shares of iHuman worth $42.7K as of Q1 2026.
- Citadel Advisors bought 4,314 iHuman shares in Q1 2026, an estimated $8K.
- iHuman made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #12461 holding.
- Citadel Advisors first reported a position in iHuman in Q2 2021 and has held it in 12 quarters since.
- Citadel Advisors's iHuman position peaked at $516K in Q2 2021.
- 7 funds tracked by Wall St. Rank held iHuman as of Q1 2026.
Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.